Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase

INTRODUCTION: Childhood chronic myeloid leukemia (CML) accounts for less than 3% of all childhood leukemias, hence, data on imatinib (IM) in adult CML patients has been largely extrapolated to children. We have analyzed our data to add to the existing literature. AIMS: Primary objective is to assess...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:South Asian J Cancer
Main Authors: Linga, Vijay Gandhi, Ganta, Ranga Raman, Kalpathi, Krishnamani Iyer, Gundeti, Sadashivudu, Rajappa, Senthil J., Digumarti, Raghunadharao, Paul, Tara Roshni, Tandon, Ashwani
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2014
Assuntos:
LEUKEMIAS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4236696/
https://ncbi.nlm.nih.gov/pubmed/25422804
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.142961
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados